Ahlers James M bought CUE

July 30, 2026 · Form 4 insider transaction

Ahlers James M bought 25,500 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
25,500
Price
$0.00
Total value
N/A
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 30, 2026
Filing dateAugust 3, 2026
Shares owned after25,500
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents the grant of restricted stock units ("RSUs"). The shares subject to the RSU vest in equal quarterly installments over four years from July 30, 2026, subject to the reporting person's continued service with the issuer through each vest date.

View the original Form 4 on SEC EDGAR